Related Experiment Video
Updated: Dec 17, 2025
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Mouse models and type 2 diabetes: translational opportunities
1MRC Harwell, Metabolism and Inflammation, Harwell Oxford Campus, Oxfordshire, UK. f.mcmurray@har.mrc.ac.uk
Abstract:
Type 2 diabetes prevalence is increasing worldwide. Treatments are available, but glycaemic control is not always effective in many patients. Better models are needed to create new and improved therapies and to expand our understanding of how type 2 diabetes begins and progresses. Translational research involves the transformation of knowledge from basic scientific discoveries to impacting on public health. This can allow identification of novel molecular mechanisms underlying the disease which can lead to preventative measures, biomarkers for diagnosis, or future therapies. Generation of genetically modified mice has allowed us to investigate the function of genes and develop reproducible models in which the phenotype of the animal can be tested. Mouse models have already given us insight into glucose metabolism and insulin secretion, identified novel pathways, and have been used to confirm genome-wide association studies. In this review we discuss the use of the mouse to clarify human genome-wide association study loci, understand genes and pathways involved in type 2 diabetes, and uncover novel targets for drug discovery.
Insights
Mouse models are crucial for understanding type 2 diabetes progression and developing new therapies. These models aid in identifying genetic links and novel drug targets for better glycaemic control.
Area of Science:
- Endocrinology and Metabolism
- Genetics and Genomics
- Translational Medicine
Background:
- Rising global prevalence of type 2 diabetes (T2D) necessitates improved therapeutic strategies.
- Current treatments often fail to achieve optimal glycaemic control in many patients.
- A deeper understanding of T2D pathogenesis is essential for developing novel interventions.
Purpose of the Study:
- To review the utility of mouse models in T2D research.
- To explore how mouse models can clarify human genome-wide association study (GWAS) findings.
- To identify genes, pathways, and drug targets relevant to T2D.
Main Methods:
- Utilizing genetically modified mouse models to study gene function and disease phenotype.
- Leveraging mouse models for translational research, bridging basic science and public health.
- Analyzing insights gained from mouse models regarding glucose metabolism and insulin secretion.
Main Results:
- Mouse models have provided significant insights into glucose homeostasis and insulin secretion mechanisms.
- These models have confirmed findings from human genome-wide association studies.
- They have facilitated the identification of novel molecular pathways implicated in T2D.
Conclusions:
- Genetically modified mouse models are invaluable tools for advancing T2D research.
- Mouse models accelerate the discovery of preventative measures, diagnostic biomarkers, and therapeutic targets.
- Continued use of mouse models is critical for developing effective T2D therapies and improving public health outcomes.
